The Clinical Efficacy of Ginkgo Leaf Injection Combined with Donepezil in the Treatment of Alzheimer's Disease Based on Cerebral Hemodynamics and Inflammatory Factors

Yamin WANG; Yuanyuan LI; Yanyun XUE

doi:10.12259/j.issn.2095-610X.S20240524

Volume 45 Issue 5

May 2024

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2024 > 45(5): 157-163

Yamin WANG, Yuanyuan LI, Yanyun XUE. The Clinical Efficacy of Ginkgo Leaf Injection Combined with Donepezil in the Treatment of Alzheimer's Disease Based on Cerebral Hemodynamics and Inflammatory Factors[J]. Journal of Kunming Medical University, 2024, 45(5): 157-163. doi: 10.12259/j.issn.2095-610X.S20240524

Citation:

Yamin WANG, Yuanyuan LI, Yanyun XUE. The Clinical Efficacy of Ginkgo Leaf Injection Combined with Donepezil in the Treatment of Alzheimer's Disease Based on Cerebral Hemodynamics and Inflammatory Factors[J]. Journal of Kunming Medical University, 2024, 45(5): 157-163. doi: 10.12259/j.issn.2095-610X.S20240524

Citation:

Yamin WANG, Yuanyuan LI, Yanyun XUE. The Clinical Efficacy of Ginkgo Leaf Injection Combined with Donepezil in the Treatment of Alzheimer's Disease Based on Cerebral Hemodynamics and Inflammatory Factors[J]. Journal of Kunming Medical University, 2024, 45(5): 157-163. doi: 10.12259/j.issn.2095-610X.S20240524

PDF( 612 KB)

The Clinical Efficacy of Ginkgo Leaf Injection Combined with Donepezil in the Treatment of Alzheimer's Disease Based on Cerebral Hemodynamics and Inflammatory Factors

doi: 10.12259/j.issn.2095-610X.S20240524

Dept. of Psychiatry，Shalingzi Hospital，Zhangjiakou Hebei 075000，China

Received Date: 2024-01-11
Available Online: 2024-04-26
Publish Date: 2024-05-31

Abstract

Abstract

Objective To explore the efficacy of combination therapy of Ginkgo biloba injection and donepezil in the treatment of Alzheimer's disease （AD） based on cerebral hemodynamics and inflammatory factors. Methods A total of 90 patients with AD in Zhangjiakou Shalingzi Hospital from March 2020 to January 2022 were randomly divided into a control group （45 cases） and a study group （45 cases）. Both groups received the conventional symptomatic treatment. On this basis, the control group was given donepezil treatment, and the study group was given ginkgo leaf injection combined with donepezil treatment. The therapeutic effects, cerebral hemodynamic parameters [mean flow velocity （MFV） and pulsatility index （PI） of bilateral middle cerebral arteries （bilateral MCA） and basilar arteries （BA）], inflammatory factors [interleukin-6 （IL-6）, tumor necrosis factor-α （TNF-α）, IL-1β], s100β protein, Aβ-amyloid 1-42 （Aβ1-42）, bradykinin （BK）, cognitive function, activities of daily living, and adverse reactions were compared between the two groups. Results Compared with the control group （77.78%）, the total effective rate of the study group （93.33%） was significantly improved （P < 0.05）; 1, 3, and 6 months after the treatment, the MFV of BA and bilateral MCA in the study group was higher than that in the control group, while the PI of BA and bilateral MCA was lower than that in the control group （P < 0.05）; The levels of serum TNF-α, IL-6, and IL-1β in the study group were lower than those in the control group 1, 3, and 6 months after the treatment （P < 0.05）; 1, 3, and 6 months after the treatment, the levels of serum s100β protein, Aβ1-42, and BK in the study group were lower than those in the control group （P < 0.05）; 1, 3, and 6 months after the treatment, the score of the mini-mental state examination scale （MMSE） in the study group was higher than that in the control group, while the scores of the AD assessment subscale cognitive scale （ADAS-cog） and activities of daily living scale （ADL） were lower than those in the control group （P < 0.05）; The incidence of adverse reactions in the study group （13.33%） was not significantly different from that in the control group （8.89%）（P > 0.05）. Conclusion The efficacy of ginkgo biloba injection combined with donepezil in the treatment of AD is significant, which may be achieved by improving cerebral hemodynamics, downregulating inflammatory factors, and regulating the levels of serum s100β protein, Aβ1-42, and BK.
- Alzheimer's disease,
- Ginkgo biloba injection,
- Donepezil,
- Cerebral hemodynamics,
- Inflammatory factor

FullText(HTML)

References(23)

References

[1]	Knopman D S,Amieva H,Petersen R C,et al. Alzheimer disease[J]. Nat Rev Dis Primers,2021,7(1):33. doi: 10.1038/s41572-021-00269-y
[2]	Penney J,Ralvenius W T,Tsai L H. Modeling Alzheimer's disease with iPSC-derived brain cells[J]. Mol Psychiatry,2020,25(1):148-167. doi: 10.1038/s41380-019-0468-3
[3]	杨云竣,黄飚. 阿尔茨海默病与帕金森病的影像组学研究进展[J]. 国际医学放射学杂志,2020,43(1):41-44.
[4]	Guo J,Wang Z,Liu R,et al. Memantine,donepezil,or combination therapy-what is the best therapy for Alzheimer's disease? A Network Meta-Analysis[J]. Brain Behav,2020,10(11):e01831. doi: 10.1002/brb3.1831
[5]	任晓蕾,刘一,詹轶秋,等. 银杏叶提取物治疗阿尔茨海默病有效性、安全性和经济性的快速卫生技术评估[J]. 中国药房,2020,31(22):2786-2790.
[6]	殷贺,刘广志. 银杏叶提取物治疗阿尔茨海默病的作用机制研究进展[J]. 中国医药,2020,15(1):151-154.
[7]	Zhang H,Wang Y,Lyu D,et al. Cerebral blood flow in mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis[J]. Ageing Res Rev,2021,71(1):101450.
[8]	潘名志,徐晓文,任秀乾,等. 阿尔茨海默病伴抑郁患者外周血炎性因子、25羟维生素D水平的研究[J]. 临床输血与检验,2021,23(1):100-103.
[9]	田金洲,解恒革,王鲁宁,等. 中国阿尔茨海默病痴呆诊疗指南(2020年版)[J]. 中华老年医学杂志,2021,40(3):269-283.
[10]	Pinto T C C,Machado L,Bulgacov T M,et al. Is the montreal cognitive assessment (MoCA) screening superior to the mini-mental state examination (MMSE) in the detection of mild cognitive impairment (MCI) and Alzheimer's disease (AD) in the elderly[J]. Int Psychogeriatr,2019,31(4):491-504. doi: 10.1017/S1041610218001370
[11]	Cogo-Moreira H,Krance S H,Wu C Y,et al. State,trait,and accumulated features of the Alzheimer's disease assessment scale cognitive subscale (ADAS-Cog) in mild Alzheimer's disease[J]. Alzheimers Dement (N Y),2023,9(1):e12376.
[12]	Bryant M S,Kang G E,Protas E J. Relation of chair rising ability to activities of daily living and physical activity in Parkinson's disease[J]. Arch Physiother,2020,10(1):22. doi: 10.1186/s40945-020-00094-8
[13]	Breijyeh Z,Karaman R. Comprehensive review on Alzheimer's disease: Causes and treatment[J]. Molecules,2020,25(24):5789. doi: 10.3390/molecules25245789
[14]	Govind N. Donepezil for dementia due to Alzheimer's disease[J]. Br J Community Nurs,2020,25(3):148-149. doi: 10.12968/bjcn.2020.25.3.148
[15]	赵萍,李新,崔静,等. 银杏叶提取物对阿尔茨海默病大鼠海马bFGF/Notch1通路的影响[J]. 中华全科医学,2021,19(8):1283-1286.
[16]	康延海,盛莉,李佳,等. 盐酸美金刚联合银杏叶提取物对阿尔茨海默病患者血清BDNF、NGF、DA水平和认知功能的影响[J]. 现代生物医学进展,2020,20(15):2944-2947,2966.
[17]	Gachowska M,Szlasa W,Saczko J,et al. Neuroregulatory role of ginkgolides[J]. Mol Biol Rep,2021,48(7):5689-5697. doi: 10.1007/s11033-021-06535-2
[18]	王红岩,张立军,洪梅,等. 阿尔茨海默病患者脑血流灌注参数与认知功能障碍的关系[J]. 中国临床医生杂志,2020,48(3):311-314.
[19]	Zheng Y,Xie Y,Qi M,et al. Ginkgo biloba extract is comparable with donepezil in improving functional recovery in Alzheimer's disease: Results from a multilevel characterized study based on clinical features and resting-state functional magnetic resonance imaging[J]. Front Pharmacol,2021,12(1):721216.
[20]	Dhapola R,Hota S S,Sarma P,et al. Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer's disease[J]. Inflammopharmacology,2021,29(6):1669-1681. doi: 10.1007/s10787-021-00889-6
[21]	付劭静,杨月明,周延华,等. 阿尔茨海默症患者血清缓激肽、s100β蛋白和Aβ1-42表达水平及与患者神经功能、认知功能的关系[J]. 河北医药,2022,44(15):2245-2249.
[22]	夏静,魏月,舒艳,等. 银杏叶提取物片联合重酒石酸卡巴拉汀治疗阿尔茨海默病的临床研究[J]. 中西医结合心脑血管病杂志,2022,20(23):4355-4359. doi: 10.12102/j.issn.1672-1349.2022.23.026
[23]	彭羽,林赟,余能伟,等. 银杏叶提取物联合低频重复经颅磁刺激治疗缺血性脑卒中的临床研究[J]. 四川大学学报:医学版,2021,52(5):7.

Relative Articles(20)

Relative Articles

[1]	Rui LI, Jianpei SU, Jin LI, Wenjun DENG, Yazhou ZHANG. A Mendelian Randomization Study on Alzheimer’ s Disease and Sarcopenia. Journal of Kunming Medical University, 2024, 45(8): 24-29. doi: 10.12259/j.issn.2095-610X.S20240804
[2]	Wensong DING, Qicai QU, Hong LI, Liu YANG, Jianping TAO, Yongyu SI. Effects of Different Fluids on Microcirculation and Inflammatory Factors in Rabbits with Hemorrhagic Shock. Journal of Kunming Medical University, 2023, 44(12): 13-19. doi: 10.12259/j.issn.2095-610X.S20231202
[3]	Xiaowei YUAN, Maohua QIN, Lijun WANG, Yuanqi DUAN. Expression of CRP，IL-6 and TNF-a in Serum of Patients with Adolescence Polycystic Ovary Syndrome. Journal of Kunming Medical University, 2022, 43(10): 136-138. doi: 10.12259/j.issn.2095-610X.S20221026
[4]	Xiaowei YUAN, Maohua QIN, Lijun WANG, Tingxian YANG, Jing JIN. Expression Characteristics of Inflammatory Factors in the Serum of Patients with Adolescence Polycystic Ovary Syndrome. Journal of Kunming Medical University, 2022, 43(5): 123-126. doi: 10.12259/j.issn.2095-610X.S20220517
[5]	Huiping HE, Yaowei HE, Zonglin SHEN, Xiaoxiao SONG, Baoluo LI, Hongyan JIANG. Comparative Analysis of Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer's Disease and Mild Cognitive Impairment. Journal of Kunming Medical University, 2022, 43(9): 19-23. doi: 10.12259/j.issn.2095-610X.S20220913
[6]	Zheng-jiang XING, Ya-xiong LI, Hong-lin ZOU, Zhen-kun YU, Wen-jun LI, Yun TANG, Zheng JIA. Effect of Regional Citric acid Anticoagulation on NLRP-3 and Downstream Inflammatory Factors Expression in Patients with AKI after Cardiopulmonary Bypass. Journal of Kunming Medical University, 2021, 42(12): 59-66. doi: 10.12259/j.issn.2095-610X.S20211221
[7]	Chen Yi . Clinical Study of Glucosidorum Tripterygll Totorum Combined with Prednisone Acetate and Hydroxychloroquine Sulfate in Treatment of Systemic Lupus Erythematosus. Journal of Kunming Medical University, 2018, 39(03): 98-102.
[8]	Deng Li, Li Jing Tao , Cao Guang Qiong . NGF-BMSCs移植对阿尔茨海默病大鼠神经行为学的改善. Journal of Kunming Medical University, 2017, 38(06): 5-8.
[9]	Huang Wei . 阿尔茨海默病的 Hcy、 CRP变化与精神行为相关性临床观察. Journal of Kunming Medical University,
[10]	Yang Jian Zhi . Effects of Multimodal Analgesia on Cytokines and Cortisol Levels in Patients Received Surgical Treatment for Radical Colon Cancer. Journal of Kunming Medical University,
[11]	Su Hui Peng . . Journal of Kunming Medical University,
[12]	He Xiao Yu . . Journal of Kunming Medical University,
[13]	Huang Wei . . Journal of Kunming Medical University,
[14]	Li Yuan . . Journal of Kunming Medical University,
[15]	Shi Guo Qiang . . Journal of Kunming Medical University,
[16]	Xu Xia . . Journal of Kunming Medical University,
[17]	Qin Min Li . . Journal of Kunming Medical University,
[18]	Ding Yan Jie . . Journal of Kunming Medical University,
[19]	Qin Min Li . . Journal of Kunming Medical University,
[20]	Hu Dong Hui . 阿立哌唑与利培酮治疗阿尔茨海默病性痴呆精神症状的临床对照. Journal of Kunming Medical University,